Back to Annual Meeting
Back to Annual Meeting
APHA Scientific Session and Event Listing
Douglas H. Huber, MD, MSc and Nika Saeedi. Management Sciences for Health, 784 Memorial Drive, Cambridge, MA 02139, 617 250 9237, email@example.com
Our purpose was to accelerate contraceptive use in three Afghan rural sites through innovations to strengthen rural community health workers (CHWs) in Afghan organizations, gain support from community leaders, and build on the USAID/MSH health initiative. The initiative was thought to be politically sensitive by both Afghan and international colleagues.
Following in-depth community assessments, we developed guidance to remove fears and misconceptions about modern contraceptives among clients, CHWs, clinicians and community leaders. The project introduced Afghanistan's first injectable services with CHWs initiating the method. Contraceptive prevalence data was collected directly from CHW community maps from October 2005 to June 2006 and externally verified by household visits.
In the three areas, we found major increases in contraceptive prevalence rates (CPR): from 9 to 34; 20 to 44; and 24 to 51 in eight months. Method-specific changes in CPR in Ghazni, Herat, and Kabul sites showed: injectables increased substantially in all three areas; oral contraceptives and condoms each increased in one area only. Diversity of contraceptive method preferences was notable, despite similar services.
Following dialogue and discussion, religious leaders, Sunni and Shia, supported the health rationale for increased birth spacing and modern contraceptives. Some provided contraceptive education during Friday prayers. CHWs successfully and safely provided first injections, convincing the MOPH to change its policy for CHWs to initiate injectable contraceptives. Documented achievements at the community level resulted in policy changes to improve access for injectable and oral contraceptives nation-wide.
Keywords: Community-Based Public Health, Contraception
Presenting author's disclosure statement:
Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.